Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024


Werte in diesem Artikel
Aktien

0.72 EUR -0.01 EUR -0.96 %

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2024, the following resources were managed through the liquidity account:

Werbung

  1. 338,789 shares
  2. € 94,328.20

In the first half of 2024, it was negotiated a total of:

Purchases204,900 shares€ 248,651894 market transactions
Sales169,972 shares€ 217,858769 market transactions

It is recalled that:

  1. as of December 31, 2023, the following resources were managed through the liquidity account:
  • 303,861 shares
  • € 125,121
  1. at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
  • 164,183 shares
  • € 246,158
  1. when the liquidity program was initially established in 2016, the following resources were made available:
  • € 500,000

Contacts

Werbung

Transgene:
Lucie Larguier
Chief Financial Officer
+33 (0)3 88 27 91 00
investorrelations@transgene.fr
 

Attachment


Werbung

Transgene Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Transgene nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.